Good morning and welcome to the Bio-Techne Corporation Annual Meeting of Shareholders. I would now like to turn the conference call over to Shane Bohnen, General Counsel and Corporate Secretary of Bio-Techne. Please go ahead. Welcome to our annual shareholders meeting. It is 8:00 A.M. Central Time on October 30th, 2025, and the meeting is called to order. Today's meeting will be limited to the business matters outlined in the proxy as after the business meeting concludes, we can take any questions shareholders may have. If you have logged into the meeting with your control number, you may ask a question by typing it into the box at the bottom of the screen at any time during this meeting. Before we turn to the business agenda, I wanted to let you know that our CEO, Kim Kelderman, and other members of our Board of Directors are attending today, as well as a representative from KPMG. Also joining me are our CFO, Jim Hippel, and our Vice President of Investor Relations, David Claire. I will serve as Secretary of this meeting and Inspector of Elections. Let's turn to today's business. The mailing of our proxy statement and card began on September 19th to shareholders of record. As of September 5th, 2025, approximately 90% of those shares are represented at this meeting by proxy. A quorum is present. We will cover four proposals today. First is to set the number of directors at nine, and second, the election of directors. All the current directors have been nominated for re-election except for Dr. Rolandussi, who has retired from the board. The third is an advisory vote on executive compensation for the named executive officers as described in the proxy. The fourth and final proposal is the ratification of the appointment of KPMG as the company's public accounting firm for the 2026 fiscal year. We will now turn our attention to the voting of shares. If you have not yet submitted a proxy card and wish to vote on these items, or wish to revoke a proxy card you had previously signed, you may vote your shares by clicking on the Vote Here button on your screen. Now you will need your control number to vote your shares online. We will now pause to allow shareholders to vote. The polls are now closed and here are the results. Based on the preliminary results, all director nominees have been elected and all of the proposals have passed. Thank you for participating in today's meeting. The meeting is now adjourned. At this point, we would be happy to take your questions. If you have a control number, you may type your question into the box at the bottom of the screen. If you have general questions about Bio-Techne, please include your contact information so we can respond directly to you after the meeting. We will now pause to allow questions to be submitted. We have received no questions. If at any time you have a question about Bio-Techne, please reach out to Vice President of Investor Relations, David Claire. His contact information is listed on our website. Thanks to all of our shareholders. This concludes our meeting for today. The meeting is now concluded, and you may now disconnect.